{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:45:31Z","timestamp":1793411131287,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015822","name":"Fondazione Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ajo.2025.02.044","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T19:02:19Z","timestamp":1741201339000},"page":"58-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Neurofibromatosis Type 1 (NF1)\u2013Related Ocular Signs: New Insights on Their Prevalence, Incidence, and Genotype-Phenotype Correlation in NF1 Children"],"prefix":"10.1016","volume":"275","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3132-6233","authenticated-orcid":false,"given":"Edoardo","family":"Midena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Cosmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2025.02.044_bib0001","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13023-023-02911-2","article-title":"Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis","volume":"18","author":"Lee","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"10.1016\/j.ajo.2025.02.044_bib0002","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/jmedgenet-2012-100978","article-title":"Neurofibromatosis type 1: from genotype to phenotype","volume":"49","author":"Pasmant","year":"2012","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.ajo.2025.02.044_bib0003","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.survophthal.2017.10.007","article-title":"Ophthalmic manifestations in neurofibromatosis type 1","volume":"63","author":"Kinori","year":"2018","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.044_bib0004","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11060-017-2517-6","article-title":"Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1","volume":"134","author":"Trevisson","year":"2017","journal-title":"J Neurooncol"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.044_bib0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ana.410410204","article-title":"Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic pathway glioma task force","volume":"41","author":"Listernick","year":"1997","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.044_bib0006","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/0883073817739509","article-title":"Optic Pathway Gliomas in Neurofibromatosis Type 1","volume":"33","author":"Campen","year":"2018","journal-title":"J Child Neurol"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.044_bib0007","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.icu.0000193070.32369.37","article-title":"Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1","volume":"17","author":"Sylvester","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.02.044_bib0008","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/neuonc\/nos076","article-title":"Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis","volume":"14","author":"Fisher","year":"2012","journal-title":"Neuro Oncol"},{"issue":"8","key":"10.1016\/j.ajo.2025.02.044_bib0009","doi-asserted-by":"crossref","first-page":"e1004","DOI":"10.1111\/aos.13803","article-title":"Correlation of peripapillary retinal nerve fibre layer thickness with visual acuity in paediatric patients affected by optic pathway glioma","volume":"96","author":"Parrozzani","year":"2018","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.02.044_bib0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(81)35034-9","article-title":"Von Recklinghausen neurofibromatosis: incidence of iris hamartomata","volume":"88","author":"Lewis","year":"1981","journal-title":"Ophthalmology"},{"issue":"9234","key":"10.1016\/j.ajo.2025.02.044_bib0011","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0140-6736(00)02716-1","article-title":"Frequency of choroidal abnormalities in neurofibromatosis type 1","volume":"356","author":"Yasunari","year":"2000","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ajo.2025.02.044_bib0012","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.ajo.2025.02.044_bib0013","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/IAE.0000000000001578","article-title":"Retinal vascular abnormalities in a large cohort of patients affected by neurofibromatosis type: 1 a study using optical coherence tomography angiography","volume":"38","author":"Parrozzani","year":"2018","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.ajo.2025.02.044_bib0014","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1542\/peds.105.3.608","article-title":"Use of the National Institutes of Health criteria for diagnosis of neurofibromatosis 1 in children","volume":"105","author":"DeBella","year":"2000","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.ajo.2025.02.044_bib0015","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/ejhg.2014.243","article-title":"Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas","volume":"23","author":"Pinna","year":"2015","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"10.1016\/j.ajo.2025.02.044_bib0016","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/humu.22392","article-title":"NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience","volume":"34","author":"Sabbagh","year":"2013","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1016\/j.ajo.2025.02.044_bib0017","doi-asserted-by":"crossref","first-page":"e616","DOI":"10.1002\/mgg3.616","article-title":"The Arg1038Gly missense variant in the NF1 gene causes a mild phenotype without neurofibromas","volume":"7","author":"Trevisson","year":"2019","journal-title":"Mol Genet Genomic Med"},{"issue":"4","key":"10.1016\/j.ajo.2025.02.044_bib0018","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3390\/cancers15041217","article-title":"Neurofibromatosis type 1: pediatric aspects and review of genotype\u2013phenotype correlations","volume":"15","author":"Peduto","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.ajo.2025.02.044_bib0019","doi-asserted-by":"crossref","first-page":"E1506","DOI":"10.1002\/humu.21271","article-title":"NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype","volume":"31","author":"Pasmant","year":"2010","journal-title":"Hum Mutat"},{"issue":"10","key":"10.1016\/j.ajo.2025.02.044_bib0020","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1136\/jmg.40.10.e109","article-title":"Evaluation of genotype-phenotype correlations in neurofibromatosis type 1","volume":"40","author":"Castle","year":"2003","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.ajo.2025.02.044_bib0021","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/cge.12873","article-title":"Choroidal abnormalities in caf\u00e9-au-lait syndromes: a new differential diagnostic tool?","volume":"91","author":"Cassiman","year":"2017","journal-title":"Clin Genet"},{"key":"10.1016\/j.ajo.2025.02.044_bib0022","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/WNO.0000000000000550","article-title":"Optic pathway gliomas in neurofibromatosis type 1: an update: surveillance, treatment indications, and biomarkers of vision","volume":"37","author":"de Blank","year":"2017","journal-title":"J Neuroophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.044_bib0023","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.spen.2017.04.006","article-title":"Optic pathway gliomas secondary to neurofibromatosis type 1","volume":"24","author":"Beres","year":"2017","journal-title":"Semin Pediatr Neurol"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.044_bib0024","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1167\/iovs.12-11385","article-title":"Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and\/or optic pathway gliomas","volume":"54","author":"Avery","year":"2013","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2025.02.044_bib0025","first-page":"1","article-title":"Screening for visual impairment in children ages 1-5 years: systematic review to update the 2004 U.S. preventive services task force recommendation","volume":"81","author":"Chou","year":"2011","journal-title":"Evid Synth"},{"issue":"10","key":"10.1016\/j.ajo.2025.02.044_bib0026","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1167\/iovs.14-16053","article-title":"In vivo detection of choroidal abnormalities related to NF1: feasibility and comparison with standard NIH diagnostic criteria in pediatric patients","volume":"56","author":"Parrozzani","year":"2015","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ajo.2025.02.044_bib0027","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.ajo.2025.02.044_bib0028","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1136\/jmg.40.6.e82","article-title":"Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients","volume":"40","author":"Ars","year":"2003","journal-title":"J Med Genet"},{"issue":"6","key":"10.1016\/j.ajo.2025.02.044_bib0029","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","article-title":"Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects","volume":"15","author":"Messiaen","year":"2000","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.044_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s10038-019-0695-0","article-title":"Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types","volume":"65","author":"Kang","year":"2020","journal-title":"J Hum Genet"},{"issue":"8","key":"10.1016\/j.ajo.2025.02.044_bib0031","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0161-6420(84)34217-8","article-title":"von Recklinghausen neurofibromatosis: II. Incidence of optic gliomata","volume":"91","author":"Lewis","year":"1984","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.044_bib0032","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3476(94)70122-9","article-title":"Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study","volume":"125","author":"Listernick","year":"1994","journal-title":"J Pediatr"},{"issue":"13","key":"10.1016\/j.ajo.2025.02.044_bib0033","doi-asserted-by":"crossref","first-page":"8112","DOI":"10.1167\/iovs.13-13093","article-title":"Optical coherence tomography in the diagnosis of optic pathway gliomas","volume":"54","author":"Parrozzani","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ajo.2025.02.044_bib0034","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.3390\/cancers11111790","article-title":"Optic pathway glioma in type 1 neurofibromatosis: review of its pathogenesis, diagnostic assessment, and treatment recommendations","volume":"11","author":"Cassina","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.044_bib0035","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2011.07.046","article-title":"Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1","volume":"119","author":"Viola","year":"2012","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2025.02.044_bib0036","doi-asserted-by":"crossref","first-page":"e667","DOI":"10.1111\/aos.12750","article-title":"Choroidal abnormalities in neurofibromatosis type 1 detected by near-infrared reflectance imaging in paediatric population","volume":"93","author":"Vagge","year":"2015","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.02.044_bib0037","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3928\/01913913-20140513-02","article-title":"Frequency of choroidal abnormalities in pediatric patients with neurofibromatosis type 1","volume":"51","author":"Goktas","year":"2014","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.044_bib0038","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.11.2.10","article-title":"Prevalence of choroidal abnormalities and Lisch nodules in children meeting clinical and molecular diagnosis of neurofibromatosis type 1","volume":"11","author":"Pimentel","year":"2022","journal-title":"Transl Vis Sci Technol"},{"issue":"5","key":"10.1016\/j.ajo.2025.02.044_bib0039","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/ceo.13936","article-title":"Long-term follow-up of choroidal abnormalities in children with neurofibromatosis type 1","volume":"49","author":"Touz\u00e9","year":"2021","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.044_bib0040","first-page":"86","article-title":"Multimodal imaging of choroidal nodules in neurofibromatosis type I","volume":"80","author":"Filip","year":"2024","journal-title":"Ces a Slov Oftalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.02.044_bib0041","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3390\/cancers14061423","article-title":"Choroidal abnormalities in pediatric NF1: a cohort natural history study","volume":"14","author":"Cosmo","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ajo.2025.02.044_bib0042","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/13816810.2021.1881977","article-title":"The presence and progression of choroidal neurofibromas in a predominantly pediatric population with neurofibromatosis type-1","volume":"42","author":"Chilibeck","year":"2021","journal-title":"Ophthalmic Genet"},{"issue":"5","key":"10.1016\/j.ajo.2025.02.044_bib0043","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/IAE.0000000000002962","article-title":"Retinal vascular abnormalities related to neurofibromatosis type 1: natural history and classification by optical coherence tomography angiography in 473 patients","volume":"41","author":"Parrozzani","year":"2021","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.ajo.2025.02.044_bib0044","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/bjo.86.3.282","article-title":"Corkscrew retinal vessels in neurofibromatosis type 1: report of 12 cases","volume":"86","author":"Muci-Mendoza","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2025.02.044_bib0045","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1136\/bjophthalmol-2018-313002","article-title":"Retinal microvascular abnormalities in neurofibromatosis type 1","volume":"103","author":"Moramarco","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2025.02.044_bib0046","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1097\/IAE.0000000000003234","article-title":"Retinal vascular abnormalities in children with neurofibromatosis type 1","volume":"41","author":"Touz\u00e9","year":"2021","journal-title":"Retina"},{"issue":"pt 1","key":"10.1016\/j.ajo.2025.02.044_bib0047","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/eye.1993.20","article-title":"Images of Lisch nodules across the spectrum","volume":"7","author":"Ragge","year":"1993","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.044_bib0048","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-0749.2004.00206.x","article-title":"Pigment cell-related manifestations in neurofibromatosis type 1: an overview","volume":"18","author":"De Schepper","year":"2005","journal-title":"Pigment Cell Res"},{"issue":"10","key":"10.1016\/j.ajo.2025.02.044_bib0049","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00417-005-1184-z","article-title":"Quantification and anatomic distribution of choroidal abnormalities in patients with type I neurofibromatosis","volume":"243","author":"Nakakura","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2025.02.044_bib0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2147\/OPTH.S56327","article-title":"Correlations between choroidal abnormalities, Lisch nodules, and age in patients with neurofibromatosis type 1","volume":"8","author":"Makino","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.044_bib0051","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00417-017-3870-z","article-title":"Near-infrared imaging: an in vivo, non-invasive diagnostic tool in neurofibromatosis type 1","volume":"256","author":"Moramarco","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.02.044_bib0052","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ajmg.a.20650","article-title":"Outcomes of systematic screening for optic pathway tumors in children with neurofibromatosis type 1","volume":"127A","author":"Blazo","year":"2004","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.044_bib0053","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejpn.2015.12.002","article-title":"Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort","volume":"20","author":"Blanchard","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"issue":"10","key":"10.1016\/j.ajo.2025.02.044_bib0054","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/01.WNL.0000144341.16830.01","article-title":"Late-onset optic pathway tumors in children with neurofibromatosis 1","volume":"63","author":"Listernick","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ajo.2025.02.044_bib0055","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0002-9394(85)90376-9","article-title":"Neurofibromatosis of the choroid","volume":"99","author":"Klein","year":"1985","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.02.044_bib0056","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/archopht.1965.00970030698019","article-title":"Nerve fibrils in ovoid bodies: with neurofibromatosis of the choroid","volume":"73","author":"Wolter","year":"1965","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2025.02.044_bib0057","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/archopht.1982.01030040919010","article-title":"Ovoid bodies in choroidal neurofibromatosis","volume":"100","author":"Kurosawa","year":"1982","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.044_bib0058","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02307012","article-title":"Choroidal ganglioneuroma in neurofibromatosis","volume":"220","author":"Woog","year":"1983","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.02.044_bib0059","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/jnc.13396","article-title":"A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1","volume":"135","author":"Esposito","year":"2015","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.044_bib0060","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/9.2.237","article-title":"Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1","volume":"9","author":"Ars","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.044_bib0061","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/humu.10299","article-title":"Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene","volume":"23","author":"Kluwe","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ajo.2025.02.044_bib0062","first-page":"315","article-title":"Detection of NF1 mutations utilizing the protein truncation test (PTT)","volume":"217","author":"Upadhyaya","year":"2003","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.044_bib0063","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10689-006-9001-3","article-title":"Molecular diagnosis of neurofibromatosis type 1: 2 years experience","volume":"6","author":"Griffiths","year":"2007","journal-title":"Fam Cancer"},{"issue":"6","key":"10.1016\/j.ajo.2025.02.044_bib0064","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/humu.9245","article-title":"Novel and recurrent mutations in the NF1 gene in Italian patients with neurofibromatosis type 1","volume":"23","author":"De Luca","year":"2004","journal-title":"Hum Mutat"},{"issue":"9","key":"10.1016\/j.ajo.2025.02.044_bib0065","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/jmg.2009.075937","article-title":"Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions","volume":"47","author":"Mautner","year":"2010","journal-title":"J Med Genet"},{"issue":"5","key":"10.1016\/j.ajo.2025.02.044_bib0066","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/374821","article-title":"Elevated risk for MPNST in NF1 microdeletion patients","volume":"72","author":"De Raedt","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.ajo.2025.02.044_bib0067","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00439-017-1766-y","article-title":"Emerging genotype\u2013phenotype relationships in patients with large NF1 deletions","volume":"136","author":"Kehrer-Sawatzki","year":"2017","journal-title":"Hum Genet"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.044_bib0068","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/510781","article-title":"An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation","volume":"80","author":"Upadhyaya","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.044_bib0069","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ajhg.2017.12.001","article-title":"Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844\u2013848","volume":"102","author":"Koczkowska","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1016\/j.ajo.2025.02.044_bib0070","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/humu.22832","article-title":"High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: genotype-phenotype correlation","volume":"36","author":"Rojnueangnit","year":"2015","journal-title":"Hum Mutat"},{"issue":"13","key":"10.1016\/j.ajo.2025.02.044_bib0071","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3390\/cancers16132406","article-title":"Genotype\u2013phenotype correlation in neurofibromatosis type 1: evidence for a mild phenotype associated with splicing variants leading to in-frame skipping of NF1 exon 24 [19a]","volume":"16","author":"Chen","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.044_bib0072","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41431-022-01236-1","article-title":"Patients carrying Arg1809 substitution with no choroidal abnormalities: a further proof of a \u201cQuasi-Incomplete\u201d NF1 phenotype","volume":"31","author":"Santoro","year":"2023","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"10.1016\/j.ajo.2025.02.044_bib0073","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3390\/cancers11121838","article-title":"Risk of optic pathway glioma in neurofibromatosis type 1: no evidence of genotype-phenotype correlations in a large independent cohort","volume":"11","author":"Melloni","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ajo.2025.02.044_bib0074","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1212\/NXG.0000000000000192","article-title":"Children with 5\u2032-end NF1 gene mutations are more likely to have glioma","volume":"3","author":"Anastasaki","year":"2017","journal-title":"Neurol Genet"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425001102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425001102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T03:55:43Z","timestamp":1777780543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425001102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":74,"alternative-id":["S0002939425001102"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.02.044","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofibromatosis Type 1 (NF1)\u2013Related Ocular Signs: New Insights on Their Prevalence, Incidence, and Genotype-Phenotype Correlation in NF1 Children","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.02.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}